APPLICATIONS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In nec lacinia neque. Proin vitae nunc.

Strategic Product Pipeline

From Molecular Discovery to Clinical Translation

Hermez Nanomedicine leverages a modular LNP platform to transform high-potential candidates into clinically viable therapeutic programs. By integrating nanoengineering and pharmacokinetic modeling, we de-risk delivery-dependent programs and accelerate advancement.

Tools Tools
Oncology Program
Tools Tools
CNS Disorders Program
Tools Tools
Metabolic Diseases Program
Tools Tools
Oncology Program
0%
Tools Tools
CNS Disorders Program
0%
Tools Tools
Metabolic Diseases Program
0%

OncologyCNS DisordersMetabolic Diseases
  • Precision Engineering

    Leveraging 30–50 nm structures to enhance tissue permeability and maximize the EPR effect in tumor tissues.

  • Therapeutic Goal

    Expanding the therapeutic index by reducing systemic toxicity and dose-limiting side effects.

  • Supported Modalities

    siRNA, mRNA, and small molecule chemotherapy.

  • Barrier Penetration

    Specifically engineered LNP surface functionalization designed to overcome biological barriers (such as the BBB).

  • Therapeutic Goal

    Enhancing pharmacokinetic control and cellular uptake within the central nervous system.

  • Supported Modalities

    Neuroprotective factors and gene therapy candidates.

  • Selective Targeting

    Programmable lipid compositions and surface modifications for tissue-selective delivery to organs like the liver or spleen.

  • Therapeutic Goal

    Achieving controlled release kinetics for systemic metabolic regulation.

  • Supported Modalities

    Peptide-based therapeutics and nucleic acid constructs.